This is a study to determine the effectiveness of a combination of SYR-322 and pioglitazone HCI (Actos) as compared to pioglitazone HCI alone in treating Type 2 diabetes. This national study is currently recruiting patients.
Read moreGood news for everyone who has been affected by the oxycodone shortage! This week the FDA approved Sun Pharmaceutical Industries'... Read more »
Hello everyone! I hope you all are having a decent week. I don't know about you but I just can't get used to these days getting dark... Read more »
By Dr. Cindy Haines, author of The New Prescription: How to Get the Best Health Care in a Broken System (HCI Books, May 2011) Americans... Read more »
The Food and Drug Administration has approved Geodon (Ziprasidone) as a maintenance treatment for bipolar I disorder. After a six month... Read more »
Making changes today for some abstract reward in the distant future may not get you too excited. However, this is exactly what we do when... Read more »
Source: HealthCentral Encyclopedia
Meniere's disease or syndrome is a condition characterized by hearing impairment, ringing in the ears (tinnitus), and periodic vertigo (disturbance... Read more »
Source: HealthCentral Encyclopedia
Pelvic inflammatory disease (PID) is the generic term used to describe a variety of infections of the female inner reproductive organs (the uterus,... Read more »
What exactly is a "black box" warning?Simply put, it's the strongest warning that the U.S. Food and Drug Administration (FDA) can require on a... Read more »